To print: Select File and then Print from your browser's menu --------------------------------------------------------------------------------------- Title: DG DISPATCH - APA: Bupropion and Hypoactive Sexual Desire Disorder URL: http://www.pslgroup.com/dg/1D2932.htm Doctor's Guide May 19, 2000
By Lara Pullen Special to DG News CHICAGO, IL -- May 19, 2000 -- Bupropion sustained release (SR) may be an effective treatment for hypoactive sexual desire disorder (HSDD) in non-depressed women. At the 2000 Annual Meeting of the American Psychiatric Association, in Chicago, IL, R. Taylor Segraves, MD, and Kathleen B. Segraves, MD, both of Case Western Reserve University, Cleveland, OH, presented the results of a multicenter, single-blind study designed to test the safety and efficacy of bupropion SR. The study included a four-week placebo phase followed by an eight-week treatment phase. Non-depressed women (n=51) were at least 20 years of age with a diagnosis of HSDD for at least the preceding six months as defined in the Diagnostic and Statistical Manual (DSM)-IV. The following variables were assessed at each biweekly clinic visit (beginning at day 0): Investigator-Rated Sexual Desire and Sexual Functioning Assessments, Clinical Global Impressions Scale for Improvement of Illness (CGI-I), and Clinical Global Impressions Scale for Severity of Illness (CGI-S). Of the 51 women who continued into the treatment phase, 15 (29 percent) were considered to be responders, with response seen as early as two weeks after beginning treatment. In addition, bupropion SR was generally well-tolerated. Dr. Kathleen Segraves believes that further study is warranted and explained, "that we saw anything in that short amount of time is excellent." Related links: Bupropion. --------------------------------------------------------------------------------------------- Copyright © 1999 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content. --------------------------------------------------------------------------------------------- This news story was printed from *Doctor's Guide to the Internet* located at http://www.docguide.com --------------------------------------------------------------------------------------- Return to News Story Page This site is maintained by webmaster@pslgroup.com Please contact us with any comments, problems or bugs. All contents Copyright (c) 1998 P\S\L Consulting Group Inc. All rights reserved.